Literature DB >> 15028853

Severe irritability associated with statin cholesterol-lowering drugs.

B A Golomb1, T Kane, J E Dimsdale.   

Abstract

BACKGROUND: As use of a drug becomes widespread, the full spectrum of its effects becomes clearer. Although a link has been suggested between low or lowered cholesterol and irritability/aggression, less is known about possible links between irritability and statins. AIM: To assess the possible connection of statin usage to severe irritability.
DESIGN: Case series.
METHODS: Six patients referred or self-referred with irritability and short temper on statin cholesterol-lowering drugs completed a survey providing information on character of behavioural effect, time-course of onset and recovery, and factors relevant to drug adverse effect causality.
RESULTS: In each case the personality disruption, once evident, was sustained until statin use was discontinued; and resolved promptly with drug cessation. In four patients, re-challenge with statins occurred, and led to recrudescence of the problem. All patients experienced other recognized statin adverse effects while on the drug. Manifestations of severe irritability included homicidal impulses, threats to others, road rage, generation of fear in family members, and damage to property. DISCUSSION: Case series invariably raise more questions than they can answer. These case reports suggest that severe irritability may occur in some statin users. Although this adverse effect may be rare, potentially life-threatening adverse effects of drugs must be taken seriously.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15028853     DOI: 10.1093/qjmed/hch035

Source DB:  PubMed          Journal:  QJM        ISSN: 1460-2393


  26 in total

Review 1.  Should we lower cholesterol as much as possible?

Authors:  Uffe Ravnskov; Paul J Rosch; Morley C Sutter; Mark C Houston
Journal:  BMJ       Date:  2006-06-03

2.  Psychologic disorders and statin use: a propensity score-matched analysis.

Authors:  Ishak Mansi; Christopher R Frei; Mary J Pugh; Eric M Mortensen
Journal:  Pharmacotherapy       Date:  2013-04-26       Impact factor: 4.705

3.  Effects of Statins and Cholesterol on Patient Aggression: Is There a Connection?

Authors:  Emily Leppien; Kimberly Mulcahy; Tammie Lee Demler; Eileen Trigoboff; Lewis Opler
Journal:  Innov Clin Neurosci       Date:  2018-04-01

Review 4.  Neuropsychiatric adverse events associated with statins: epidemiology, pathophysiology, prevention and management.

Authors:  Marco Tuccori; Sabrina Montagnani; Stefania Mantarro; Alice Capogrosso-Sansone; Elisa Ruggiero; Alessandra Saporiti; Luca Antonioli; Matteo Fornai; Corrado Blandizzi
Journal:  CNS Drugs       Date:  2014-03       Impact factor: 5.749

5.  Association of statin use with sleep disturbances: data mining of a spontaneous reporting database and a prescription database.

Authors:  Mitsutaka Takada; Mai Fujimoto; Kohei Yamazaki; Masashi Takamoto; Kouichi Hosomi
Journal:  Drug Saf       Date:  2014-06       Impact factor: 5.606

Review 6.  Screening, diagnosis & monitoring of depression/distress in CHF patients.

Authors:  Mark W Ketterer; Walter Knysz
Journal:  Heart Fail Rev       Date:  2007-08-01       Impact factor: 4.214

7.  Cardiovascular drugs and the risk of suicide: a nested case-control study.

Authors:  Torbjörn Callréus; Ulla Agerskov Andersen; Jesper Hallas; Morten Andersen
Journal:  Eur J Clin Pharmacol       Date:  2007-03-20       Impact factor: 2.953

8.  Association of Long-Term Atorvastatin with Escalated Stroke-Induced Neuroinflammation in Rats.

Authors:  Leila Simani; Nima Naderi; Fariba Khodagholi; Masoud Mehrpour; Sanaz Nasoohi
Journal:  J Mol Neurosci       Date:  2016-08-19       Impact factor: 3.444

9.  Physician response to patient reports of adverse drug effects: implications for patient-targeted adverse effect surveillance.

Authors:  Beatrice A Golomb; John J McGraw; Marcella A Evans; Joel E Dimsdale
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

Review 10.  Statin adverse effects : a review of the literature and evidence for a mitochondrial mechanism.

Authors:  Beatrice A Golomb; Marcella A Evans
Journal:  Am J Cardiovasc Drugs       Date:  2008       Impact factor: 3.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.